Chiara Sueri

887 total citations
19 papers, 471 citations indexed

About

Chiara Sueri is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Chiara Sueri has authored 19 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Chiara Sueri's work include Epilepsy research and treatment (9 papers), Neuroscience and Neuropharmacology Research (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Chiara Sueri is often cited by papers focused on Epilepsy research and treatment (9 papers), Neuroscience and Neuropharmacology Research (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Chiara Sueri collaborates with scholars based in Italy, Greece and United Kingdom. Chiara Sueri's co-authors include Sara Gasparini, Umberto Aguglia, Edoardo Ferlazzo, Angelo Labate, Antonio Gambardella, Vittoria Cianci, Emilio Russo, Vincenzo Belcastro, Ettore Beghi and Pasquale Striano and has published in prestigious journals such as PLoS ONE, Neurology and Epilepsia.

In The Last Decade

Chiara Sueri

18 papers receiving 461 citations

Peers

Chiara Sueri
Ekrem Kutluay United States
Basanagoud Mudigoudar United States
Walter M. Palm Netherlands
Jiwon Lee South Korea
Chiara Sueri
Citations per year, relative to Chiara Sueri Chiara Sueri (= 1×) peers Vittoria Cianci

Countries citing papers authored by Chiara Sueri

Since Specialization
Citations

This map shows the geographic impact of Chiara Sueri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Sueri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Sueri more than expected).

Fields of papers citing papers by Chiara Sueri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Sueri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Sueri. The network helps show where Chiara Sueri may publish in the future.

Co-authorship network of co-authors of Chiara Sueri

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Sueri. A scholar is included among the top collaborators of Chiara Sueri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Sueri. Chiara Sueri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ferlazzo, Edoardo, et al.. (2021). Dystonia in Angelman syndrome: a common, unrecognized clinical finding. Journal of Neurology. 268(6). 2208–2212. 5 indexed citations
2.
Coppola, Antonietta, Alessia Zarabla, Andrea Maialetti, et al.. (2020). Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study). Frontiers in Neurology. 11. 592–592. 44 indexed citations
3.
Ferlazzo, Edoardo, Giuseppe Gobbi, Sara Gasparini, et al.. (2019). Epilepsy, cerebral calcifications, and gluten-related disorders: Are anti-transglutaminase 6 antibodies the missing link?. Seizure. 73. 17–20. 6 indexed citations
4.
Ferlazzo, Edoardo, Silvana Franceschetti, Sara Gasparini, et al.. (2019). Connectivity measures suggest a sub-cortical generator of myoclonus in Angelman syndrome. Clinical Neurophysiology. 130(12). 2231–2237. 3 indexed citations
5.
Ferlazzo, Edoardo, Sara Gasparini, Vittoria Cianci, et al.. (2018). Seizures with Migraine-like Attacks after Radiation Therapy (SMART): A new meaning of an old acronym. Seizure. 60. 94–95. 10 indexed citations
6.
Gasparini, Sara, Chiara Sueri, Vittoria Cianci, et al.. (2018). Need for a standardized technique of nap EEG recordings: results of a national online survey in Italy. Neurological Sciences. 39(11). 1911–1915. 1 indexed citations
7.
Gasparini, Sara, Edoardo Ferlazzo, Vittoria Cianci, et al.. (2018). Epileptogenic role of occult temporal encephalomeningocele. Neurology. 90(14). e1200–e1203. 19 indexed citations
8.
Gasparini, Sara, Maurizio Campolo, Cosimo Ieracitano, et al.. (2018). Information Theoretic-Based Interpretation of a Deep Neural Network Approach in Diagnosing Psychogenic Non-Epileptic Seizures. Entropy. 20(2). 43–43. 29 indexed citations
9.
Sueri, Chiara, Sara Gasparini, Simona Balestrini, et al.. (2018). Diagnostic Biomarkers of Epilepsy. Current Pharmaceutical Biotechnology. 19(6). 440–450. 19 indexed citations
10.
Sueri, Chiara, Edoardo Ferlazzo, Maurizio Elia, et al.. (2017). Epilepsy and sleep disorders improve in adolescents and adults with Angelman syndrome: A multicenter study on 46 patients. Epilepsy & Behavior. 75. 225–229. 20 indexed citations
11.
Gasparini, Sara, et al.. (2017). A commercially available device suppresses photic driving: implications for EEG recording. Neurological Sciences. 39(4). 761–763.
12.
Gasparini, Sara, Edoardo Ferlazzo, Chiara Sueri, et al.. (2017). Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis. Neurological Sciences. 38(3). 399–406. 29 indexed citations
13.
Ferlazzo, Edoardo, Chiara Sueri, Sara Gasparini, et al.. (2017). Methodological issues associated with clinical trials in epilepsy. Expert Review of Clinical Pharmacology. 10(10). 1103–1108. 7 indexed citations
14.
Ferlazzo, Edoardo, Chiara Sueri, Sara Gasparini, & Umberto Aguglia. (2016). Challenges in the pharmacological management of epilepsy and its causes in the elderly. Pharmacological Research. 106. 21–26. 41 indexed citations
15.
Gasparini, Sara, Edoardo Ferlazzo, Vittoria Cianci, et al.. (2016). The Natural History of Epilepsy in 163 Untreated Patients: Looking for “Oligoepilepsy”. PLoS ONE. 11(9). e0161722–e0161722. 4 indexed citations
16.
Morabito, Francesco Carlo, Maurizio Campolo, Nadia Mammone, et al.. (2016). Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia. International Journal of Neural Systems. 27(2). 1650039–1650039. 94 indexed citations
17.
Gasparini, Sara, Edoardo Ferlazzo, Giorgia Giussani, et al.. (2016). Rapid versus slow withdrawal of antiepileptic monotherapy in 2-year seizure-free adult patients with epilepsy (RASLOW) study: a pragmatic multicentre, prospective, randomized, controlled study. Neurological Sciences. 37(4). 579–583. 3 indexed citations
18.
Ferlazzo, Edoardo, Sara Gasparini, Ettore Beghi, et al.. (2016). Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta‐analysis of risk factors. Epilepsia. 57(8). 1205–1214. 122 indexed citations
19.
Ferlazzo, Edoardo, Emilio Russo, Laura Mumoli, et al.. (2015). Profile of brivaracetam and its potential in the treatment of epilepsy. Neuropsychiatric Disease and Treatment. 11. 2967–2967. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026